Current Cancer Drug Targets logo Bentham Science Publishers logo

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Related content
Volume 12, Number 9, November 2012

< previous issue | all issues | next issue >

Articles

Acknowledgement
pp. i-iii(3)

mTOR as a Potential Target for the Prevention and Treatment of Hepatocellular Carcinoma
pp. 1045-1061(17)
Authors: Elisa Buitrago-Molina, Laura; Vogel, Arndt

Targeted Therapy for Liver Cancer: Updated Review in 2012
pp. 1062-1072(11)
Author: Kudo, Masatoshi

Non-Coding RNAs as Therapeutic Targets in Hepatocellular Cancer
pp. 1073-1080(8)
Authors: Braconi, Chiara; Patel, Tushar

Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma
pp. 1081-1094(14)
Authors: W.C. Pang, Roberta; T.P. Poon, Ronnie

Angiogenesis in Hepatocellular Carcinoma: A Potential Target for Chemoprevention and Therapy
pp. 1095-1118(24)
Authors: Bishayee, Anupam; S. Darvesh, Altaf

Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects
pp. 1119-1128(10)
Authors: Shimizu, Masahito; Imai, Kenji; Takai, Koji; Moriwaki, Hisataka

Prevention of Hepatocellular Carcinoma: Potential Targets, Experimental Models, and Clinical Challenges
pp. 1129-1159(31)
Authors: Hoshida, Yujin; C. Fuchs, Bryan; K. Tanabe, Kenneth

Chemoprevention of Hepatocarcinogenesis with Dietary Isoprenic Derivatives: Cellular and Molecular Aspects
pp. 1173-1190(18)
Authors: Prates Ong, Thomas; Testoni Cardozo, Monica; de Conti, Aline; Salvador Moreno, Fernando

Dietary Phytochemicals in the Chemoprevention and Treatment of Hepatocellular Carcinoma: In Vivo Evidence, Molecular Targets, and Clinical Relevance
pp. 1191-1232(42)
Authors: Bishayee, Anupam; J. Thoppil, Roslin; Waghray, Abhijeet; A. Kruse, Jaclyn; A. Novotny, Nicholas; S. Darvesh, Altaf

Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma
pp. 1233-1243(11)
Authors: K.M. Chow, Ariel; Ng, Lui; Sing Li, Hung; Cheng, Chi Wai; S.C. Lam, Colin; C.C. Yau, Thomas; N.M. Cheng, Paul; Tat Fan, Sheung; T.P. Poon, Ronnie; W.C. Pang, Roberta

Black Currant Anthocyanins Abrogate Oxidative Stress through Nrf2- Mediated Antioxidant Mechanisms in a Rat Model of Hepatocellular Carcinoma
pp. 1244-1257(14)
Authors: J. Thoppil, Roslin; Bhatia, Deepak; F. Barnes, Kendra; Haznagy-Radnai, Erzsebet; Hohmann, Judit; S. Darvesh, Altaf; Bishayee, Anupam

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page